Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX® (collagenase clostridium...

Related Keywords

Dublin ,Ireland ,Canada ,Canadian ,Matthewj Ziegelmann ,Matthew Ziegelmann ,Genzhou Liu ,Landon Trost ,Qinfang Xiang ,Michaelp Mclane ,Exchange Commission ,Endo International ,Prnewswire Endo International ,Linkedin ,Treatment Response ,Cycle With Collagenase Clostridium Histolyticum ,Pooled Analysis ,Two Phase ,Risk Evaluation ,Mitigation Strategy ,Including Anaphylaxis ,Abnormal Coagulation ,Post Injection Back Pain Reactions ,Prescribing Information ,Boxed Warning ,Private Securities Litigation Reform Act ,Bankruptcy Code ,Annual Report ,Quarterly Reports ,Endo International Plc ,